STAT

Vaccines are part of the solution to the emerging crisis of antibiotic resistance

Wiser use of antibiotics is one solution to the growing crisis of antibiotic resistance. Wider use of vaccines is another.
Vials of cholera vaccine in a medical camp in South Sudan.

Superhero. Superhighway. Superglue. Adding the prefix “super” highlights a thing’s unrivaled rank and elevates it above and beyond what is expected. But superbug has a different connotation. These microbes are increasingly resistant to currently available antibiotics, turning what should be easily treatable infections into deadly ones. Wiser use of antibiotics is one solution. Wider use of vaccines is another.

Each year, drug-resistant infections are responsible for 23,000 deaths in the United States. If current trends hold, projected that by 2050, 10 million people worldwide will die annually from untreatable infections. That’s almost as many lives as we will lose to all forms of cancer this year. The World Bank warns that the long-term economic damage from drug resistance than the 2008 financial crisis.

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: Medicare’s Big Experiment To Fix Kidney Failure Care Hasn’t Worked So Far, Studies Say
An enormous experiment by Medicare shows a null effect: Financial incentives haven't gotten dialysis providers to move more patients to home dialysis or transplant. 
STAT1 min read
Moderna Receives $176 Million From BARDA For MRNA Influenza Vaccines
Moderna will receive $176 million from HHS' BARDA to accelerate development of mRNA-based pandemic influenza vaccines, the company said Tuesday.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FTC Probing Teva Patents, A Moderna Flu Vaccine Contract, And More
The FTC is investigating Teva Pharmaceuticals after it refused to remove about two dozen patents for asthma and COPD inhalers from a federal registry.

Related Books & Audiobooks